BNP Paribas Financial Markets’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $107 | Hold |
62
| – | – | ﹤0.01% | 4506 |
|
2025
Q1 | $105 | Hold |
62
| – | – | ﹤0.01% | 4416 |
|
2024
Q4 | $138 | Buy |
+62
| New | +$138 | ﹤0.01% | 4406 |
|
2022
Q2 | – | Sell |
-67
| Closed | -$442 | – | 3522 |
|
2022
Q1 | $442 | Hold |
67
| – | – | ﹤0.01% | 3455 |
|
2021
Q4 | $427 | Sell |
67
-5
| -7% | -$32 | ﹤0.01% | 3469 |
|
2021
Q3 | $1.01K | Hold |
72
| – | – | ﹤0.01% | 3269 |
|
2021
Q2 | $1.34K | Sell |
72
-503
| -87% | -$9.38K | ﹤0.01% | 3322 |
|
2021
Q1 | $13.4K | Sell |
575
-339
| -37% | -$7.91K | ﹤0.01% | 3233 |
|
2020
Q4 | $17.1K | Sell |
914
-105
| -10% | -$1.97K | ﹤0.01% | 3217 |
|
2020
Q3 | $25.9K | Buy |
1,019
+707
| +227% | +$18K | ﹤0.01% | 3118 |
|
2020
Q2 | $9K | Sell |
312
-905
| -74% | -$26.1K | ﹤0.01% | 3129 |
|
2020
Q1 | $58.6K | Buy |
1,217
+656
| +117% | +$31.6K | ﹤0.01% | 2858 |
|
2019
Q4 | $31.9K | Sell |
561
-41
| -7% | -$2.33K | ﹤0.01% | 3194 |
|
2019
Q3 | $37.3K | Buy |
602
+170
| +39% | +$10.5K | ﹤0.01% | 3008 |
|
2019
Q2 | $19.4K | Sell |
432
-369
| -46% | -$16.6K | ﹤0.01% | 3285 |
|
2019
Q1 | $50.3K | Buy |
801
+800
| +80,000% | +$50.3K | ﹤0.01% | 2904 |
|
2018
Q4 | $67 | Sell |
1
-139
| -99% | -$9.31K | ﹤0.01% | 3546 |
|
2018
Q3 | $14.1K | Hold |
140
| – | – | ﹤0.01% | 2918 |
|
2018
Q2 | $9.26K | Sell |
140
-526
| -79% | -$34.8K | ﹤0.01% | 3164 |
|
2018
Q1 | $33.3K | Sell |
666
-9
| -1% | -$450 | ﹤0.01% | 3165 |
|
2017
Q4 | $32.7K | Buy |
675
+112
| +20% | +$5.42K | ﹤0.01% | 3181 |
|
2017
Q3 | $34.2K | Buy |
563
+274
| +95% | +$16.7K | ﹤0.01% | 2860 |
|
2017
Q2 | $20.5K | Buy |
289
+279
| +2,790% | +$19.8K | ﹤0.01% | 3112 |
|
2017
Q1 | $664 | Sell |
10
-123
| -92% | -$8.17K | ﹤0.01% | 3207 |
|
2016
Q4 | $12.5K | Sell |
133
-32
| -19% | -$3.01K | ﹤0.01% | 2821 |
|
2016
Q3 | $18.6K | Buy |
165
+86
| +109% | +$9.7K | ﹤0.01% | 2933 |
|
2016
Q2 | $6.45K | Buy |
+79
| New | +$6.45K | ﹤0.01% | 3137 |
|